TY - JOUR
T1 - Assessment and treatment of depression in patients with cardiovascular disease
T2 - National Heart, Lung, and Blood Institute working group report
AU - Davidson, Karina W.
AU - Kupfer, David J.
AU - Bigger, J. Thomas
AU - Califf, Robert M.
AU - Carney, Robert M.
AU - Coyne, James C.
AU - Czajkowski, Susan M.
AU - Frank, Ellen
AU - Frasure-Smith, Nancy
AU - Freedland, Kenneth E.
AU - Froelicher, Erika S.
AU - Glassman, Alexander H.
AU - Katon, Wayne J.
AU - Kaufmann, Peter G.
AU - Kessler, Ronald C.
AU - Kraemer, Helena C.
AU - Krishnan, K. Ranga R.
AU - Lespérance, François
AU - Rieckmann, Nina
AU - Sheps, David S.
AU - Suls, Jerry M.
PY - 2006/9
Y1 - 2006/9
N2 - OBJECTIVE: The National Heart, Lung, and Blood Institute convened an interdisciplinary working group of experts to develop recommendations for the assessment and treatment of depression in patients with coronary heart disease (CHD). METHOD: Consensus of experts. RESULTS: Our current recommendations are that the Beck Depression Inventory-I be employed for epidemiological studies of depression and CHD, that the Patient Health Questionnaire 2-item version be employed for screening for trial eligibility, that the Depression Interview and Structured Hamilton (DISH) be employed for diagnostic ascertainment for trial inclusion, and that the Hamilton rating scale, which is part of the DISH, be employed for both depression symptom reduction and the remission criterion in any trial. We further recommend that a randomized controlled trial be undertaken to determine whether selective serotonin reuptake inhibitors, psychotherapy, or combined treatment can reduce the risk of CHD events and mortality associated with depression in CHD patients. CONCLUSIONS: This report summarizes the recommendations made by the working group and discusses the rationale for each recommendation, the strengths and weaknesses of alternative approaches to assessment and treatment, and the implications for future research in this area.
AB - OBJECTIVE: The National Heart, Lung, and Blood Institute convened an interdisciplinary working group of experts to develop recommendations for the assessment and treatment of depression in patients with coronary heart disease (CHD). METHOD: Consensus of experts. RESULTS: Our current recommendations are that the Beck Depression Inventory-I be employed for epidemiological studies of depression and CHD, that the Patient Health Questionnaire 2-item version be employed for screening for trial eligibility, that the Depression Interview and Structured Hamilton (DISH) be employed for diagnostic ascertainment for trial inclusion, and that the Hamilton rating scale, which is part of the DISH, be employed for both depression symptom reduction and the remission criterion in any trial. We further recommend that a randomized controlled trial be undertaken to determine whether selective serotonin reuptake inhibitors, psychotherapy, or combined treatment can reduce the risk of CHD events and mortality associated with depression in CHD patients. CONCLUSIONS: This report summarizes the recommendations made by the working group and discusses the rationale for each recommendation, the strengths and weaknesses of alternative approaches to assessment and treatment, and the implications for future research in this area.
KW - Assessment
KW - Cardiovascular diseases
KW - Consensus
KW - Depression
KW - Recommendations
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=33749021908&partnerID=8YFLogxK
U2 - 10.1097/01.psy.0000233233.48738.22
DO - 10.1097/01.psy.0000233233.48738.22
M3 - Article
C2 - 17012516
AN - SCOPUS:33749021908
SN - 0033-3174
VL - 68
SP - 645
EP - 650
JO - Psychosomatic Medicine
JF - Psychosomatic Medicine
IS - 5
ER -